Anna Kotyza is the Content Director at VentureOut, creating content for VentureOut programs. Holding a strong background in storytelling, film-making, virtual reality, business development, strategy, research, video editing, content creation, and media.
Prior to VentureOut, Anna studied visual and media art production at Emerson University. And currently studying arts, business, technology and innovation in New York University.

Elena de Amicis is working as Medical Strategist. She has nine years of experience in the health-care industry. Previously she was working for Intouchsolution as a medical strategist.

She has a passion for transforming scientific facts into actionable marketing insights and points of differentiation.

Matt Swulinski is a serial entrepreneur, strategist, and growth hacker that leverages a data-driven approach while focusing on cutting through the noise and driving ROI for startups & enterprises. He combines Fortune 500 Innovation Consulting experience with learnings from founding his own startups to help accelerate growth for other companies. He serves as a Mentor & Startup Advisor at various VC firms and startup accelerators, delivering value through coaching & teaching growth marketing boot camps around the US.

Brent Stackhouse is the Managing Director of Mount Sinai Ventures, the venture investment arm of the Mount Sinai Health System in New York City. His responsibilities include diversifying the portfolio of strategic investments to enhance Mount Sinai’s transition to population health management. He represents Mount Sinai on the board of several portfolio companies, including ambulatory surgery and urgent care centers. He is experienced in public health and health information technology, and serves on Mount Sinai telehealth strategy committee, the Junto Collaborative for health innovation, and is a mentor for the Blueprint Health technology incubator.

Peter is best known as the founder of Medscape. While he was CEO of SCP Communications, Inc., Peter was inducted into the Medical Advertising Hall of Fame in 2013, and he has been listed as one of the 1,000 most creative people in the U.S. He is past president of the Healthcare Marketing & Communications Council, Inc., a director of both Crossix and Context Matters and a member of the Medical Advisory Boards of Everyday Health, Milestone Venture Partners, TrialX, and the Markle Foundation’s Connecting for Health Initiative. A frequent guest speaker and widely published author, Peter holds an M.S. in journalism from Columbia University and a B.A. from New York University.

Sam Newbold has been supporting VentureOut companies to secure US visas since 2013. He is experienced in a wide range of employment based, family based, and investment based immigration issues, working closely with the global startup and tech communities, representing cutting edge companies and talented individuals who comprise New York’s rapidly growing Silicon Alley.

Mr. Newbold also works closely with foreign investors seeking nonimmigrant or immigrant status through EB5 or E-2 investments, and he is also experienced in helping foreign business owners receive L visa status through establishing New Offices in the United States.

As a business lawyer, Joseph represents startups to publicly-held technology, life science and consumer companies, venture capital and private equity funds and investment banks in a wide range of seed and venture financings, mergers and acquisitions, IPOs and other public offerings. Joseph has represented issuers and underwriters in dozens of IPOs and follow-on public offerings involving companies in the technology, life sciences and consumer sectors, including leading investment banks such as Credit Suisse, Morgan Stanley, and Oppenheimer.

He is currently a partner and Co-Chair of the Venture Capital & Emerging Companies Practice of McCarter, a 400+ lawyer U.S. law firm with a global practice.

Randy is the founder of CipherHealth. He currently directs all areas of financing, Health Information Technology (HIT), legal and HR.

Prior to founding CipherHealth, Randy managed business development for MDLand International, a CCHIT accredited electronic medical record (EMR) company located in New York City.

Prior experience also includes consulting for Empath Consulting and sales management at Abbott Laboratories

Randy received a Master of Public Health (MPH) from Yale University where he received a Wilbur G. Downs Fellowship to research Malaria in South Africa.

Omid joined ZA Ventures in 2017. Before joining ZA Ventures, he was the Investment Principal at MVM. Prior, he was the Director of Strategy and Business Development for Becton Dickinson’s $1.3B diagnostics business. Omid was also a management consultant in Monitor Deloitte’s Life Sciences and Healthcare team.

Omid holds a Masters in Bioengineering Innovation & Design from the Johns Hopkins University and a Bachelors in Biomedical Engineering from the University of Virginia. He was also awarded a Fulbright Fellowship to conduct research on access to healthcare in the Middle East.

Olivia Musmanno is Partner at Quake Capital.

Quake Capital is a unique accelerator focused on making seed level investments in new and early-stage ventures across a wide range of industries. Working closely with key advisers, and tapping into exclusive relationships developed over the last 30 years, our team boasts unparalleled access to the top players in finance, development, manufacturing, and distribution.

Joseph Schneier is the founder and CEO of Trusty.care, a company dedicated to improving the financial and health outcomes of older adults. He has been working at solving complex social issues for the past twenty years. With a commitment to leaving the world a better place, Jo has been privileged to build products around early childhood literacy, foreign language acquisition, workforce development and has also conducted research on behalf of the Department of State, USAID, Johns Hopkins SAIS, and many other organizations. 

Mr. Schneier is a frequent speaker and mentor and has recently spoken at TEDMed, Lake Nona and StartupHealth JP Morgan. He is a mentor at Cornell, NYU, Columbia and Wharton. Cognition is a Techstars and StartupHealth company and won the 1776 Challenge Cup.

Alex developed a leading healthcare innovation focused crowdfunding site and created a healthcare CrowdChallenge model to help partners and investors crowdsource and market test the best ideas in healthcare. He leads a team of up to 35 professionals in open innovation, product development, and business development programs for clients and sponsors including GE, Pfizer, Takeda, J & J, HHS, Aetna, the American Heart Association, the American Medical Association and over 70 more.

Ryan represents health care and life sciences clients in a wide range of litigation, regulatory, and transactional matters, but has particular expertise in the areas of privacy law compliance and health care fraud litigation.

John is an accomplished, broad-based FDA quality, regulatory and compliance expert with more than 30 years of experience developing and leading quality, regulatory and compliance initiatives at top FDA-regulated companies. His unique background as a chemical engineer and attorney provides the ability to support complex technical, operational, regulatory and legal issues within FDA-regulated companies.

As a startup founder with multiple exits, He thinks there are a lot of things broken with the way that entrepreneurs approach sales and marketing in today’s complex market. His team’s focus in 2018 is to make sure they can help as many people as they can scale their businesses without running out of money. He has knowledge of various fields that is helpful for startups and also can provide insight into many areas such as Team Building & Strategic Planning, Corporate Innovation & Partnerships, Growth Hacking & Lead Generation, Marketing & Community Engagement, Seed & Venture Capital, Emerging Trends & Digital Technology.

Lexie Kier is a Principal Strategist and Founder of AOK Group, a growth consultancy for startups. She advises bold brands and startups on fundraising, customer insights, branding and marketing and often takes on interim leadership roles to help with periods of intense change, entry into new markets, and expansion.

Previously, Lexie founded Cuurio, an index of startups and innovation platform helping bold brands find clarity, context, and connection. ​Cuurio helped a growing number of innovative brands and agencies (including Warner Brother, Johnson & Johnson, L'Oreal, and J. Walter Thompson) to create vibrant native mobile partnerships that activated consumers in new channels.

Joy is an experienced founder, investment evaluator, and advisor to high growth innovative companies across sectors seeking to scale sustainably. She advises on partnerships, business modeling, go to market strategy, operations, and financial modeling. Joy has advised dozens of companies across geographies from M&A and strategic planning to process improvement and supply chain management.

Joy is an active advisor across accelerators and university startup communities including VentureOut, Techstars, I2F CyberNYC, Cal Hacks, and Columbia University’s Entrepreneurship Design Studio.  Joy is an alumna of Columbia Business School, The London School of Economics, and UC Berkeley.

Rachel Tornheim is a Healthcare Strategy Consultant who has 14 years of experience in management professionals across consulting, hospital administration, health tech, and health plans. She has an MBA at Masters of Engineering Management and a BA in Computer Science.

Lisa is the Founder and CEO of AccentC3. At AccentC3 the accent is on communication with their desired audience, clarity in their speech, and confidence communicating in a new cultural landscape. They have worked with people in several industries, from technology to finance, "big law" and healthcare. They also work with a global clientele from countries such as Brazil, Russia, China, France, and Italy.

Lisa also has a lot of experience in this field. She graduated from The University of Cambridge with an ESOL Certificate in English Teaching to Adults. Lisa has been a Speech and Language Pathologist for many companies, even as an independent consultant.

Iyah Romm is cofounder and CEO of Cityblock, a New York City start-up focused on improving the health of underserved urban populations.

During early career positions at the Massachusetts Health Policy Commission and Commonwealth Care Alliance, Mr. Romm began a fundamental re-thinking of the services, technology, and payment models that drive health care.

Brent is CEO & Co-founder at Condensed.

Brent leads condensed.io, a tight team of digital branding specialists helping startups find their identity and reach new heights. Brent is also a product designer and co-founder with Keepers Coffee Soda and BollyX.

Stephanie Philbin, a partner in the firm’s FDA group and a member of its Life Sciences practice, concentrates on Food and Drug Administration laws. She joined Goodwin in 2007.

Dr. Matthew Rosenberg is working at FundRX as Venture Partner.

Dr. Matthew Rosenberg invests in private and public entities, predominantly in healthcare. He previously founded and sold Opake, a cloud-based SaaS solution to power practice management. Beforehand, he worked at McKinsey & Company, where he advised clients in the payor, provider, medical device and pharmaceutical industries. In addition, he served as an Independent Director of a publicly-traded medical device company. Matthew received his bachelor's Phi Beta Kappa from Harvard and his MD from Yale.

Alice is a strong community builder who brings people together and stakeholders into partnerships. She is also a connector that bridges the United States with Asian countries.

Debra Perry advises regulated biological product, pharmaceutical, and medical device companies on legal and compliance issues during the development, marketing and distribution phases of their products. She provides strategic planning and risk management guidance regarding FDA submissions, conduct of clinical trials, enforcement issues, and post-approval promotional, marketing and labeling issues.

Amenichi Consulting, LLC is the leading consulting firm in FDA regulatory, compliance, business development, and market strategy for Japan-related engagements. Lead by bilingual consultants, our goal is to become the number one resource for life science companies dealing with Japan-related opportunities. The primary services of the Amenichi Consulting, LLC are: To provide consulting support for Japanese life science companies in Regulatory and Quality System compliance To provide Business Development and Market Strategies support for Japanese life science companies in entering the US To provide support to Japanese life science companies in expanding their business to US market To provide support to non-Japanese life science companies in expanding its business to Japanese market To provide Compliance support for Japanese life science companies in entering the US market To provide support in contract negotiation and supply chain management

Most recently, as Executive Vice President of Douglaston Development from 2005-18, Jonathan oversaw the development, construction, management and disposition of over $2 billion worth of market rate rental, hospitality, mixed use and condominium developments locally and nationally. Before joining Douglaston Development, Jonathan was Senior Vice President of Development of Forest City Ratner, responsible for the development of the approximately 4,500 planned residential units associated with the Barclays Stadium complex in Brooklyn.  Prior to that position, he was the Executive Vice President of the New York City Economic Development Corporation and an Officer of the New York City Industrial Development Agency for 8 years.  All totaled Jonathan had executive responsibility over $20 billion worth of projects.  With his deep connections to investors and municipal economic development programs, Jon Fair has been an invaluable asset to the Fund and MedStartr Portfolio companies connecting the best startups and MedStartr teams to investors and communities that are interested in getting involved in healthcare innovation.

Robert brings with him relationships across a wide range of businesses and a skill set of leadership, growth, strategy, restructure, deal-making and initiative to improve portfolio companies performances and identify new investments in the Medstartr family of funds.  Prior to Medstartr, Robert and his partners structured the mergers, and acquisition of their companies to one of the largest real estate companies in the US. As private investor, Robert has actively engaged and participated in the turnaround of several early stage investments and subsequent successful exits. Robert’s addition to Medstartr Ventures has helped expand the platform and deal flow with the goal of finding, funding, and accelerating best in class startup companies and identify new investments to create additional value in our Medstartr venture fund and to find the best solutions in healthcare.

Steve is an experienced HealthTech Investor & Executive and is the Director of Innovation at Dialyze Direct LLC in New York. Berman identifies, evaluates and pilots new technologies to improve patient care, and efficiencies for providers and IT staff. He performed this function while at Montefiore for the past 10 years.

He is on the Board of Directors of the HITLab at Columbia University, and partners with many incubators and technology accelerators. Prior to joining Montefiore in 2008, Mr. Berman worked on Wall Street for Merrill Lynch, and started three profitable companies. His breadth of experience, including his start-ups, which span lawn and garden, oral care and health care industries, provide him with a unique len to assess the long-term viability of new technologies.

Mr. Berman is a Certified Public Accountant, received his M.B.A. from the University of Virginia, Darden School of Business and graduated with a bachelor’s degree in business administration and accounting from Boston University.

Prior to joining Dreamit, Adam has held various senior management roles in sales, marketing, product development, clinical affairs, operations, and general management. His career has focused exclusively on building early stage venture-backed health tech companies. He has co-founded five health technology companies which have raised over $60M in early-stage capital.

Charles LaCalle devotes much of his time to analyzing edtech and digital health startups as potential investments for Dreamit. He also heads community management for the 250+ Dreamit portfolio companies.

Prior to joining DreamitCharles worked as an associate at Flatiron Investors, a seed-stage investment firm. He gained operational experience as a project manager at Allied Health Media (education technology) and a product associate at LearnVest (fintech). Charles holds a dual degree in Government and History of Art and Architecture from Harvard University. He is also on the board of StartOutwhich provides mentoring for LGBT founders and is an active mentor in Big BrothersBig Sisters.

The Clean Sell is a B2B customer development execution firm that works with corporate innovation teams, established companies expanding to the U.S. market and rapid-growth startups.

Dom is also a Senior Consultant at JJellyfish where he leads engagements with startup clients looking to understand product/market fit for Enterprise clients, accelerate market traction, and optimize their go-to-market enterprise sales activities across their entire sales cycle.